DelveInsight has launched a new report on Primary Progressive Multiple Sclerosis Epidemiology
Primary-progressive multiple sclerosis (PPMS) is a neurodegenerative disease that interferes with the brain’s ability to control the body. There are four main types of MS: relapsing-remitting MS (RRMS), primary-progressive MS (PPMS), secondary-progressive MS (SPMS), and progressive-relapsing MS. Each type might be mild, moderate, or severe.
Request for free sample copy- https://www.delveinsight.com/sample-request/primary-progressive-multiple-sclerosis-ppms-epidemiology-forecast
Primary Progressive Multiple Sclerosis Epidemiology historical as well as forecasted Primary Progressive Multiple Sclerosis Epidemiology in the 7MM, covering the United States, EU5 (Germany, France, Italy, Spain and the United Kingdom), and Japan from 2018–2030
Primary Progressive Multiple Sclerosis Epidemiology
PPMS can be further characterized at different points in time as either active (with an occasional relapse and/or evidence of new MRI activity) or not active, as well as with progression (evidence of disease worsening on an objective measure of change over time, with or without relapse or new MRI activity) or without progression. The occurrence and severity of PPMS symptoms vary with each person. Symptoms include headaches, pain in the legs and feet, back pain, muscle spasms, trouble in walking, vision problems, etc. In addition, this condition affects men and women equally.
Key facts of the Primary Progressive Multiple Sclerosis Epidemiology Report
Primary Progressive Multiple Sclerosis Epidemiology Segmentation
Primary Progressive Multiple Sclerosis Treatment
Primary-progressive multiple sclerosis (PPMS) is a rare disease subtype characterized by continuous disability worsening from the onset. It is noteworthy that the accumulation of disability without relapses characterizes PPMS, due to which the PPMS course occurs from the onset, whereas secondary progressive MS (SPMS) course follows a relapsing-remitting phase. The ultimate goal in PPMS therapy focuses on the reversal of disability and the arrest of disease progression. In general, the current treatment of PPMS is based on the severity of the disease, and these treatment approaches are symptomatic and supportive in nature.
Primary Progressive Multiple Sclerosis Epidemiology Report Highlights
Table of content
1. Key Insights
2. Executive Summary of Primary Progressive Multiple Sclerosis (PPMS)
3. Primary Progressive Multiple Sclerosis (PPMS): Disease Background and Overview
4. Patient Journey
5. Epidemiology and Patient Population
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. KOL Views
8. Unmet Needs
9. Appendix
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Reasons to buy
The Primary Progressive Multiple Sclerosis (PPMS) Epidemiology report will allow the user to –
Related Reports
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash Bhardwaj Email: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 Country: United StatesWebsite: www.delveinsight.com/